These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32114985)

  • 21. Assessment of lymphatic filariasis prior to re-starting mass drug administration campaigns in coastal Kenya.
    Njenga SM; Kanyi HM; Mutungi FM; Okoyo C; Matendechero HS; Pullan RL; Halliday KE; Brooker SJ; Wamae CN; Onsongo JK; Won KY
    Parasit Vectors; 2017 Feb; 10(1):99. PubMed ID: 28228160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community perspectives on persistent transmission of lymphatic filariasis in three hotspot districts in Ghana after 15 rounds of mass drug administration: a qualitative assessment.
    Ahorlu CSK; Koka E; Adu-Amankwah S; Otchere J; de Souza DK
    BMC Public Health; 2018 Feb; 18(1):238. PubMed ID: 29433461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of MDA registers for Lymphatic Filariasis: Findings, and potential uses in addressing the endgame elimination challenges.
    de Souza DK; Gass K; Otchere J; Htet YM; Asiedu O; Marfo B; Biritwum NK; Boakye DA; Ahorlu CS
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008306. PubMed ID: 32407319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-compliance to Mass Drug Administration Associated with the Low Perception of the Community Members About their Susceptibility to Lymphatic Filariasis in Ankobra, Ghana.
    Dicko I; Coulibaly YI; Sangaré M; Sarfo B; Nortey PA
    Infect Disord Drug Targets; 2020; 20(2):167-174. PubMed ID: 30727921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motivation-opportunity-ability-behaviour of community members and program implementers towards mass drug administration for lymphatic filariasis elimination in India: a systematic review and implementation priority.
    Sinha A; Mohapatra S; Sahoo KC; Mohanty S; Sahoo B; Pati S; Sahoo PK
    Trans R Soc Trop Med Hyg; 2024 Jul; 118(7):426-435. PubMed ID: 38506271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar.
    Dickson BFR; Graves PM; Aye NN; Nwe TW; Wai T; Win SS; Shwe M; Douglass J; Wood P; Wangdi K; McBride WJ
    Parasit Vectors; 2021 Jan; 14(1):72. PubMed ID: 33482891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Lymphatic Filariasis Data Quality in Endemic Communities in Ghana, Using the Neglected Tropical Diseases Data Quality Assessment Tool for Preventive Chemotherapy.
    de Souza DK; Yirenkyi E; Otchere J; Biritwum NK; Ameme DK; Sackey S; Ahorlu C; Wilson MD
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004590. PubMed ID: 27028010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of gender relations in uptake of mass drug administration for lymphatic filariasis in Alor District, Indonesia.
    Krentel A; Wellings K
    Parasit Vectors; 2018 Mar; 11(1):179. PubMed ID: 29530082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community views on mass drug administration for filariasis: a qualitative evidence synthesis.
    Taylor M; Thomas R; Oliver S; Garner P
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013638. PubMed ID: 35174482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia.
    Titaley CR; Damayanti R; Soeharno N; Mu'asyaroh A; Bradley M; Lynam T; Krentel A
    Parasit Vectors; 2018 May; 11(1):315. PubMed ID: 29801511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COMMUNITY MEMBERS' PERCEPTIONS OF MASS DRUG ADMINISTRATION FOR CONTROL OF LYMPHATIC FILARIASIS IN RURAL AND URBAN TANZANIA.
    Kisoka WJ; Tersbøl BP; Meyrowitsch DW; Simonsen PE; Mushi DL
    J Biosoc Sci; 2016 Jan; 48(1):94-112. PubMed ID: 25790081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in Uganda.
    Chami GF; Kabatereine NB; Tukahebwa EM
    BMC Med; 2019 Mar; 17(1):69. PubMed ID: 30917824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
    Lahariya C; Mishra A
    J Vector Borne Dis; 2008 Dec; 45(4):313-20. PubMed ID: 19248659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What Is Needed to Eradicate Lymphatic Filariasis? A Model-Based Assessment on the Impact of Scaling Up Mass Drug Administration Programs.
    Kastner RJ; Stone CM; Steinmann P; Tanner M; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(10):e0004147. PubMed ID: 26451729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
    Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
    Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
    Krentel A; Fischer PU; Weil GJ
    PLoS Negl Trop Dis; 2013 Nov; 7(11):e2447. PubMed ID: 24278486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of findings from the literature and a qualitative research study on the impacts of gender, disability, and ethnicity in Neglected Tropical Diseases programs.
    Arney JK; Headland MK; Bertone AM; Meite A; Ettiegne-Traore V; Asemanyi-Mensah K; Dede Teiko Dzathor I; Kargbo-Labour I; Jalloh U; Houck P; Stukel D
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011782. PubMed ID: 38048347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mixed-methods exploration into the resilience of community drug distributors conducting mass drug administration for preventive chemotherapy of lymphatic filariasis and onchocerciasis in Côte d'Ivoire and Uganda.
    Dilliott D; Addiss D; Thickstun C; Djima AM; Comoe E; Thompson L; Neema S; Amuyunzu-Nyamongo M; Wung-Buh A; McFarland D; Gyapong M; Krentel A
    PLOS Glob Public Health; 2022; 2(7):e0000700. PubMed ID: 36962463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.